Search

Your search keyword '"Duvoux, Christophe"' showing total 771 results

Search Constraints

Start Over You searched for: Author "Duvoux, Christophe" Remove constraint Author: "Duvoux, Christophe"
771 results on '"Duvoux, Christophe"'

Search Results

1. Type of calcineurin inhibitor and long-term outcomes following liver transplantation in patients with primary biliary cholangitis – an ELTR study

2. Evaluation of a delayed liver transplantation strategy for patients with HCC receiving bridging therapy: the DELTA-HCC study

3. The liver in sickle cell disease

4. Artificial Intelligence and liver: Opportunities and barriers

8. R3-AFP score is a new composite tool to refine prediction of hepatocellular carcinoma recurrence after liver transplantation

9. Early liver transplantation for severe alcohol-related hepatitis not responding to medical treatment: a prospective controlled study

10. THU-494 Selective internal radiation therapy for unresectable hepatocellular carcinoma in a tertiary center in France, update and final analysis

11. SAT-010 Elaboration of a one-year mortality score for first elective liver transplantation recipients over 60 years based on the results of the french national cohort between 2007 and 2017

13. FRI-171 Paediatric solid organ transplant recipients (SOTR) demonstrate greater serological response to initial SARS-CoV-2 vaccination than adult SOTR, and comparable rates of antibody degradation

14. GS-010 Early liver transplantation for severe alcohol-related hepatitis: long-term data of the french-belgian controlled study (QuickTrans)

15. SAT-048 Long-term mortality and risk factors associated with mortality after liver transplantation in the modern era

16. LBP-026 The global prospective observational study to evaluate the role of ‘liver transplantation in patients with cirrhosis and severe acuteon-chronic liver failure (CHANCE)’: study design, demographics and overall outcome

17. LBO-004 Excess waitlist mortality and survival benefit of liver transplantation for patients with severe acute-on-chronic liver failure: Interim results of the CHANCE study

18. Type of calcineurin inhibitor and long-term outcomes following liver transplantation in patients with Primary Biliary Cholangitis- an ELTR study

20. International study on the outcome of locoregional therapy for liver transplant in hepatocellular carcinoma beyond Milan criteria

22. Liver transplantation for patients with acute-on-chronic liver failure (ACLF) in Europe: Results of the ELITA/EF-CLIF collaborative study (ECLIS)

23. Covid-19 in liver transplant recipients: the French SOT COVID registry

24. Risk factors of de novo malignancies after liver transplantation: a French national study on 11004 adult patients

26. Early liver transplantation for corticosteroid non-responders with acute severe autoimmune hepatitis: The SURFASA score

27. Long term results of liver transplantation for alpha-1 antitrypsin deficiency

29. Protective Role of Tacrolimus, Deleterious Role of Age and Comorbidities in Liver Transplant Recipients With Covid-19: Results From the ELITA/ELTR Multi-center European Study

30. Selective internal radiation therapy for unresectable HCC: The SIRT downstaging study.

31. Heart Transplantation, Either Alone or Combined With Liver and Kidney, a Viable Treatment Option for Selected Patients With Severe Cardiac Amyloidosis

32. Outcomes of liver transplantation for non-alcoholic steatohepatitis: A European Liver Transplant Registry study

33. Autoimmune hepatitis recurrence after liver transplantation: “Les jeux sont faits”.

35. Autoimmune hepatitis recurrence after liver transplantation: “Les jeux sont faits”

37. Impact of DAAs on liver transplantation: Major effects on the evolution of indications and results. An ELITA study based on the ELTR registry

38. Vascular invasion and survival after liver transplantation for hepatocellular carcinoma: a study from the European Liver Transplant Registry

39. Positron emission tomography/computed tomography with 18F-fluorocholine improve tumor staging and treatment allocation in patients with hepatocellular carcinoma

40. Effectiveness and safety of anti-TNF therapy for inflammatory bowel disease in liver transplant recipients for primary sclerosing cholangitis: A nationwide case series

42. Comparison of the effect of direct-acting antiviral with and without ribavirin on cyclosporine and tacrolimus clearance values: results from the ANRS CO23 CUPILT cohort

44. Artificial Intelligence and liver: Opportunities and barriers

45. Tacrolimus Exposure Before and After a Switch From Twice-Daily Immediate-Release to Once-Daily Prolonged Release Tacrolimus: The ENVARSWITCH Study

46. Bariatric surgery and liver transplantation, here we are now: A French nationwide retrospective study

47. Direct-acting antiviral agent–based regimen for HCV recurrence after combined liver-kidney transplantation: Results from the ANRS CO23 CUPILT study

49. Persistence of Virologic Response after Liver Transplant in Hepatitis C Patients Treated with Ledipasvir / Sofosbuvir Plus Ribavirin Pretransplant

50. Validation of the AFP model as a predictor of HCC recurrence in patients with viral hepatitis-related cirrhosis who had received a liver transplant for HCC

Catalog

Books, media, physical & digital resources